
Given that PMA right Factor Xa activates the BCR downstream kinase, Protein Kinase C, consequently ERK and Egr 1, this suggests that the energetic PKC ERK pathway can partially circumvent the blocking of BCR signaling induced by SFK inhibition. CpG activates Toll like receptor 9 mediated signaling pathways. CpG can rescue immature B lymphoma cells from BCR mediated apoptosis by inducing a sustained activation of NF B, and subsequent expression of Bcl xL and c Myc and an up regulation of Egr 1. In general, the human B lymphoma cell lines required greater doses of SFK inhibitors than murine B lymphoma cells to induce development inhibition. There was quite little apoptosis in the SFK inhibitor treated human B lymphomas. We showed that this could be related to enhanced expression of anti apoptotic proteins Bcl 2 and Bcl xL by the human B lymphomas compared to the murine lymphomas.
Furthermore, constitutive expression of Bcl xL produced the WEHI 231 cell line significantly less susceptible to SFK induced apoptosis. Our data advise that the constitutive BCR signaling in B lymphoma cells is most likely due to constitutive activation of Lyn, the upstream enzyme necessary for tyrosine large-scale peptide synthesis phosphorylation of Igand Ig. Our scientific studies are in basic agreement with a current report by Yang et al. about the effects of dasatinib on lymphoma growth in vitro. They compared dasatinib to Imatinib to assistance the concept that SFK but not other tyrosine kinases are essential for lymphoma growth. Nonetheless, proteomic approaches have demonstrated that dasatinib can have an effect on other PTKs like BTK, Csk, as effectively as other Ser/Thr kinases like p38 MAPK. As a result, our study utilized siRNA to specifically knock down Lyn and as a result demonstrated Lyn is necessary for lymphoma development.
Additionally, we had been capable to show dasatinib efficacy in an in vivo lymphoma model. The obvious question is: Why is Lyn kinase constitutively energetic in B lymphoma cells 1 possibility is that Lyn is mutated in B lymphoma cells, which could be unlikely, since Lyn is active in a amount of murine and human lymphoma cells. An additional probability is that Lyn is constitutively active NSCLC due to the association of Lyn with lipid rafts that dont have the unfavorable regulator Csk in B lymphoma cells.
No comments:
Post a Comment